Impact of human bladder cancer cell architecture on autologous T‐lymphocyte activation

To investigate the influence of tumor cell architecture on T‐cell activation, we used an autologous human model based on 2 bladder tumor cell lines as targets for cytotoxic tumor‐infiltrating lymphocytes (TILs). These tumor cell lines were grown in vitro as either standard 2‐dimensional (2D) monolayers or 3‐dimensional (3D) spheroids. T‐cell activation was determined by measuring the production of three major cytokines (tumor necrosis factor, granulocyte/macrophage colony‐stimulating factor and interferon‐γ), known to be secreted by most activated TILs. Changes in the architecture of target cells from 2D to 3D induced a dramatic decrease in their capacity for stimulating TILs. Interestingly, neither TIL infiltration nor MHC class I, B7.1 costimulatory or lymphocyte function‐associated factor‐3 adhesion molecule downregulation played a major role in this decrease. These findings demonstrate that tumor architecture has a major impact on T‐cell activation and might be implicated in the escape of tumor cells from the immune system. © 2001 Wiley‐Liss, Inc.

[1]  J. Armitage Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. , 1998, Blood.

[2]  C. Viret,et al.  LFA‐3 co‐stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR‐independent activation signal , 1998, European journal of immunology.

[3]  P. Scardino,et al.  A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. , 1991, The New England journal of medicine.

[4]  T. Espevik,et al.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.

[5]  F. Marincola,et al.  Melanoma vaccines: the paradox of T cell activation without clinical response , 2000, Cancer Chemotherapy and Pharmacology.

[6]  A. Bergeron,et al.  Influence of spatial configuration on the expression of carcinoembryonic antigen and mucin antigens in human bladder cancer , 1997, International journal of cancer.

[7]  E. Parra,et al.  T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. , 1995, Critical reviews in immunology.

[8]  M. Poupon,et al.  Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. , 1997, Cancer research.

[9]  E. Jaffee,et al.  Cancer Vaccines , 1997, Current protocols in human genetics.

[10]  S. Rosenberg,et al.  Human tumor antigens for cancer vaccine development , 1999, Immunological reviews.

[11]  C. Naus,et al.  Radiation response of connexin43-transfected cells in relation to the "contact effect". , 1997, Experimental cell research.

[12]  C. Y. Wang,et al.  TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. , 1996, Science.

[13]  R. Knuechel,et al.  Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology , 1998, International journal of experimental pathology.

[14]  S. von Kleist,et al.  Study of the resistance of tumor‐cell spheroids to penetration and lysis by activated effector cells , 1994, International journal of cancer.

[15]  F. Marincola,et al.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. , 2000, Advances in immunology.

[16]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.

[17]  M. T. Santini,et al.  Differential expression of adhesion molecules (CD44, ICAM-1 and LFA-3) in cancer cells grown in monolayer or as multicellular spheroids. , 1999, Anticancer research.

[18]  B. Bodey,et al.  Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. , 2000, Anticancer research.

[19]  M. Knapp,et al.  Adaptation of EGF receptor signal transduction to three‐dimensional culture conditions: Changes in surface receptor expression and protein tyrosine phosphorylation , 1994, Journal of cellular physiology.

[20]  V. Paradis,et al.  MHC‐dependent cytolysis of autologous tumor cells by lymphocytes infiltrating urothelial carcinomas , 1997, International journal of cancer.

[21]  Maria Teresa Santini,et al.  Three-Dimensional Spheroid Model in Tumor Biology , 1999, Pathobiology.

[22]  S. Rosenberg,et al.  Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

[23]  T. Whiteside,et al.  Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  J. D. Young,et al.  Cellular and humoral mechanisms of cytotoxicity: structural and functional analogies. , 1987, Advances in immunology.

[25]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[26]  T. Nederman Effects of vinblastine and 5-fluorouracil on human glioma and thyroid cancer cell monolayers and spheroids. , 1984, Cancer Research.

[27]  S. Rosenberg,et al.  Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulation. , 1991, Journal of immunology.